title: Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by golimumab.
authors.affiliation: Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
authors.forename: Shiang-Yu
authors.initials: SY
authors.lastname: Yang
authors.affiliation: Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.|Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
authors.forename: Cheng-Che
authors.initials: CC
authors.lastname: Lan
authors.affiliation: Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.|Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
authors.forename: Stephen Chu-Sung
authors.initials: SC
authors.lastname: Hu
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy; D001707:Biopsy, Needle; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology*; D004359:Drug Therapy, Combination; D005076:Exanthema / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006633:Histamine Antagonists / Q000008:administration & dosage; D006801:Humans; D007150:Immunohistochemistry; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D006633:Histamine Antagonists; C529000:golimumab